The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Mesalamine capsules for the treatment of active Crohn's disease: Results of a 16-week trial
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis
Schroeder, K. W., Tremaine, W. J., & Ilstrup, D. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712243172603 · Cited by 3,026
A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITY
Harvey, R. F., & Bradshaw, J. M. (1980) · The Lancet · doi:10.1016/s0140-6736(80)92767-1 · Cited by 2,959
National Cooperative Crohn's Disease Study: Results of drug treatment
Summers, R. W., Switz, D. M., Sessions, J. T., Becktel, J. M., Best, W. R., Kern, F., & Singleton, J. W. (1979) · Gastroenterology · doi:10.1016/0016-5085(79)90385-8 · Cited by 1,239
Self-citationEuropean Cooperative Crohn's Disease Study (ECCDS): Results of drug treatment
Malchow, H., Ewe, K., Brandes, J. W., Goebell, H., Ehms, H., Sommer, H., & Jesdinsky, H. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90409-8 · Cited by 933
AN EXPERIMENT TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINE
Khan, A. K. A., Piris, J., & Truelove, S. C. (1977) · The Lancet · doi:10.1016/s0140-6736(77)90831-5 · Cited by 814
Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI)
Best, W. R., Becktel, J. M., & Singleton, J. W. (1979) · Gastroenterology · doi:10.1016/0016-5085(79)90384-6 · Cited by 562
Self-citationAn index of inflammatory activity in patients with Crohn's disease.
van Hees, P. A., van Elteren, P. H., van Lier, H. J., & van Tongeren, J. H. (1980) · Gut · doi:10.1136/gut.21.4.279 · Cited by 331
Klotz, U., Maier, K., Fischer, C., & Heinkel, K. (1980) · New England Journal of Medicine · doi:10.1056/nejm198012253032602 · Cited by 322
National Cooperative Crohn's Disease Study: Adverse reactions to study drugs
Singleton, J. W., Law, D. H., Kelley, M. L., Mekhjian, H. S., & Sturdevant, R. A. L. (1979) · Gastroenterology · doi:10.1016/0016-5085(79)90386-x · Cited by 263
Self-citationSulfasalazine: Pharmacology, Clinical Use, Toxicity, and Related New Drug Development
PEPPERCORN, M. A. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-3-377 · Cited by 241
Self-citation
Cited by
Inflammatory bowel disease: clinical aspects and established and evolving therapies
Baumgart, D. C., & Sandborn, W. J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60751-x · Cited by 1,920
Dignass, A., Van Assche, G., Lindsay, J. O., Lémann, M., Söderholm, J., Colombel, J. F., Danese, S., D'Hoore, A., Gassull, M., Gomollón, F., et al. (2010) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2009.12.002 · Cited by 1,498
ACG Clinical Guideline: Management of Crohn's Disease in Adults
Lichtenstein, G. R., Loftus, E. V., Isaacs, K. L., Regueiro, M. D., Gerson, L. B., & Sands, B. E. (2018) · American Journal of Gastroenterology · doi:10.1038/ajg.2018.27 · Cited by 1,421
Guidelines for the management of inflammatory bowel disease in adults
Mowat, C., Cole, A., Windsor, A., Ahmad, T., Arnott, I., Driscoll, R., Mitton, S., Orchard, T., Rutter, M., Younge, L., et al. (2011) · Gut · doi:10.1136/gut.2010.224154 · Cited by 1,419
ECCO guidelines on therapeutics in Crohn's disease: medical treatment
Torres, J., Bonovas, S., Doherty, G., Kucharzik, T., Gisbert, J. P., Raine, T., Adamina, M., Armuzzi, A., Bachmann, O., Bager, P., et al. (2020) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjz180 · Cited by 1,374
Metadata
- Authors
- Singleton, J. W., Hanauer, S. B., Gitnick, G. L., Peppercorn, M. A., Robinson, M. G., Wruble, L. D., & Krawitt, E. L.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 1993-05
- Volume
- 104
- Issue
- 5
- Pages
- 1293-1301
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W1573810982
- Cited by
- 357
- References
- 13
- FWCI
- 9.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mesalamine capsules for the treatment of active Crohn's disease: Results of a 16-week trial. https://app.cochat.ai/papers/10.1016/0016-5085(93)90337-c
- The paper
- Singleton, J. W., Hanauer, S. B., Gitnick, G. L., Peppercorn, M. A., Robinson, M. G., Wruble, L. D., & Krawitt, E. L. (1993). Mesalamine capsules for the treatment of active Crohn's disease: Results of a 16-week trial. Gastroenterology. https://doi.org/10.1016/0016-5085(93)90337-c
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.